Skip to main content

CITIGROUP INC

Position in NBIX — Neurocrine Biosciences Inc

CIK 831001 NEW YORK, NY

Position in NBIX

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$14,813,107
+$165,900 QoQ
Shares Held
112,442
+8.9% QoQ
Ownership
0.112%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Derivatives in NBIX

reported options exposure · as of Mar 31, 2026
CallValue
$2,371,320
CallShares
18,000
PutValue
$2,371,320
PutShares
18,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

CITIGROUP INC holds $466,960,833 across 57 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (3.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 NBIX
Neurocrine Biosciences Inc
This page
112,442 $14,813,107

All Filings in NBIX

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $14,813,107 112,442
2026-03-31 $2,371,320 18,000
2026-03-31 $2,371,320 18,000
2025-12-31 $4,254,900 30,000
2025-12-31 $14,647,207 103,273
2025-12-31 $4,254,900 30,000
2025-09-30 $33,281,569 237,082
2025-06-30 $40,480,221 322,064
2025-03-31 $6,304,200 57,000
2025-03-31 $6,304,200 57,000
2025-03-31 $51,560,501 466,189
2024-12-31 $22,547,068 165,180
2024-12-31 $3,685,500 27,000
2024-12-31 $3,685,500 27,000
2024-09-30 $5,277,076 45,800
2024-09-30 $23,103,796 200,519
2024-09-30 $6,855,590 59,500
2024-06-30 $16,009,503 116,289
2024-03-31 $4,137,600 30,000
2024-03-31 $21,388,355 155,078
2024-03-31 $4,137,600 30,000
2023-12-31 $22,653,889 171,933
2023-12-31 $3,952,800 30,000
2023-12-31 $3,952,800 30,000
2023-09-30 $21,357,898 189,848
2023-06-30 $5,658,000 60,000
2023-06-30 $19,720,108 209,121
2023-06-30 $5,658,000 60,000
2023-03-31 $22,145,618 218,787
2023-03-31 $3,036,600 30,000
2023-03-31 $3,036,600 30,000
2022-12-31 $16,479,851 137,976
2022-09-30 $2,017,990 19,000
2022-09-30 $2,017,990 19,000
2022-09-30 $14,400,588 135,586
2022-06-30 $9,251,727 94,909
2022-06-30 $126,724 1,300
2022-03-31 $5,794,217 61,805
2021-12-31 $9,092,831 106,761
2021-09-30 $6,083,090 63,425
2021-06-30 $10,043,520 103,201
2021-03-31 $10,675,812 109,777
2020-12-31 $1,370,655 14,300
2020-12-31 $10,258,248 107,024
2020-12-31 $1,111,860 11,600
2020-09-30 $7,529,328 78,300
2020-09-30 $8,324,955 86,574
2020-09-30 $576,960 6,000
2020-06-30 $1,244,400 10,200
2020-06-30 $8,576,600 70,300